Tafolecimab Biosimilar (PCSK9 Reference Antibody)

SKU: orb2704042

Description

Tafolecimab (IBI-306) is a human lgG2 monoclonal antibody that specifically binds PCSK-9 and reduces LDL-C levels by inhibiting PCSK-9-mediated endocytosis of the LDL receptor, which in turn enhances clearance of LDL-C and leads to a reduction in LDL-C levels. Tafolecimab may be used in studies of hypercholesterolaemia.

Images & Validation

−

Key Properties

−

Antibody Type	Biosimilar Antibody
Clonality	Monoclonal
Target	Tafolecimab Biosimilar(Anti-PCSK9 Reference Antibody)
Purity	>98%
Conjugation	Unconjugated

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Quick Database Links

Gene Symbol

Tafolecimab Biosimilar(Anti-PCSK9 Reference Antibody)

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols